THC Biomed Intl Ltd. Share Price Deutsche Boerse AG

Equities

TFHD

CA87243W1032

Pharmaceuticals

Delayed Deutsche Boerse AG 12:31:51 02/02/2024 pm IST 5-day change 1st Jan Change
0.011 EUR -.--% Intraday chart for THC Biomed Intl Ltd. -.--% +46.67%

Financials

Sales 2021 2.63M 1.92M 1.79M 160M Sales 2022 2.45M 1.79M 1.67M 150M Capitalization 7.38M 5.39M 5.02M 450M
Net income 2021 -6M -4.39M -4.08M -366M Net income 2022 -3M -2.19M -2.04M -183M EV / Sales 2021 8.24 x
Net Debt 2021 4.46M 3.26M 3.03M 272M Net Debt 2022 4M 2.93M 2.72M 244M EV / Sales 2022 4.65 x
P/E ratio 2021
-2.7 x
P/E ratio 2022
-2.41 x
Employees 35
Yield 2021 *
-
Yield 2022
-
Free-Float 68.87%
More Fundamentals * Assessed data
Dynamic Chart
THC Biomed Intl Ltd. Introduces Always Hi New Brand Catering to Maturing Cannabis Consumer Trends CI
Thc Biomed Intl Ltd. Launches New Summer Cannabis Product: Thc Kiss Strawberry Tangerine Gummies CI
THC Biomed Intl Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023 CI
THC Biomed Intl Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023 CI
THC Biomed Intl Ltd. acquired 40% stake in THC BioMed Co. Ltd for $0.06 million. CI
THC Biomed Intl Ltd. to Open First Medical Cannabis Dispensary in Asia CI
THC Biomed Intl Ltd. Announces CBD KISS Mango Beverage Shot and CBD Biscuits Begin sales in Ontario CI
THC Biomed Intl Ltd. Reports Earnings Results for the First Quarter Ended October 31, 2022 CI
THC Biomed Intl Ltd. Auditor Raises 'Going Concern' Doubt CI
THC Biomed Intl Ltd. Reports Earnings Results for the Full Year Ended July 31, 2022 CI
THC Biomed Intl Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022 CI
THC Biomed Intl Ltd. Announces Broker and Commercial Sales Agreement with World Wide Brands Limited CI
THC Biomed Intl Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022 CI
THC BioMed Intl Ltd. Announces Availability of THC KISS Cannabis Biscuits to Consumers Through Ontario Cannabis Store Online and Wholesale to Ontario Retail Stores CI
THC Biomed Intl Ltd. Grants Licence by Overseas Government to Cultivate Cannabis for Medical and Scientific Use CI
More news
Current year
0.00
Extreme 0.004
0.01
1 year
0.00
Extreme 0.004
0.03
3 years
0.00
Extreme 0.0022
0.10
5 years
0.00
Extreme 0.0022
0.24
10 years
0.00
Extreme 0.0022
2.02
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 14/15/14
Director of Finance/CFO 48 14/15/14
Members of the board TitleAgeSince
Director of Finance/CFO 48 14/15/14
Chief Executive Officer 57 14/15/14
Director/Board Member - 13/17/13
More insiders
THC Biomed Intl Ltd. is a Canada-based cannabis company. The Company is engaged in the production of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is also engaged in scientific research and the development of products and services, with patient safety as a guiding principle. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho).
More about the company

Annual profits - Rate of surprise